Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Aerosolized prostacyclin in acute respiratory distress syndrome caused by Chlamydiaceae spp. pneumonia.

Author information

Affiliations

  • 1. Department of Internal Medicine, Division of Intensive Care, Albert Schweitzer Hospital, Location Amstelwijck, P.O. Box 444, 3300 AK Dordrecht, The Netherlands.
      Authors
    • Miesen WM 1
    (1 author)

The Netherlands Journal of Medicine, 01 Aug 2001, 59(2):57-61
https://doi.org/10.1016/s0300-2977(01)00120-6 PMID: 11476913 

Abstract 

Management of respiratory failure in acute respiratory distress syndrome (ARDS) typically requires ventilatory assistance. If traditional approaches to mechanical ventilation and adjunctive measures fail to succeed in achieving adequate oxygenation, alternative measures should be considered. We describe an ARDS patient with respiratory failure caused by a severe Chlamydiaceae species community-acquired pneumonia (CAP). Aerosolized prostacyclin (PGI(2)) treatment was successfully instituted for refractory hypoxemia.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/s0300-2977(01)00120-6

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.